Opinion/decision on a Paediatric investigation plan (PIP): Feraccru, ferric maltol, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: P/0503/2023

Submitted by Anonymous (not verified) on 19 February 2025 - 16:10

Opinion/decision on a Paediatric investigation plan (PIP): Feraccru, ferric maltol, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: P/0503/2023

Human medicines European public assessment report (EPAR): Zoely, nomegestrol,estradiol, Date of authorisation: 26/07/2011, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 19 February 2025 - 14:52

Human medicines European public assessment report (EPAR): Zoely, nomegestrol,estradiol, Date of authorisation: 26/07/2011, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 19 February 2025 - 13:12

Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness